Best Single Medication for Chronic Cough
For chronic cough, the specific medication depends critically on the underlying cause: levodropropizine or moguisteine for chronic bronchitis (Grade A), or morphine sulfate 5-10 mg twice daily for refractory chronic cough that has failed specific treatments.
Algorithm for Medication Selection
Step 1: Identify if Chronic Bronchitis is Present
If the patient has chronic bronchitis with productive cough:
First-line: Levodropropizine or moguisteine 1
- These peripheral cough suppressants have Grade A recommendation with substantial benefit and good evidence
- Use for short-term symptomatic relief
- Superior to central suppressants in this context
Alternative: Codeine or dextromethorphan 1
- Grade B recommendation (fair evidence, intermediate benefit)
- Less preferred than peripheral suppressants
- Also for short-term use only
Step 2: If No Bronchitis or Treatment-Resistant
For refractory chronic cough (failed specific treatments for underlying causes):
- Morphine sulfate: 5 mg twice daily (slow-release) 2
- Start at 5 mg twice daily
- Can escalate to 10 mg twice daily if needed
- Demonstrated 40% reduction in daily cough scores (p < 0.01)
- Improved Leicester Cough Questionnaire by 3.2 points (p < 0.01)
- Two-thirds of patients required dose escalation to 10 mg
- Similar efficacy at both 5 mg and 10 mg doses after 3 months
Step 3: Alternative Neuromodulators
If opioids are contraindicated or not tolerated:
- Targets neuronal hypersensitivity
- Repurposed from neuropathic pain treatment
- Centrally-acting neuromodulator
Pregabalin or tramadol 4
- Alternative neuromodulators for cough hypersensitivity
Critical Evidence Hierarchy
The 2006 ACCP guidelines 1 provide the strongest Grade A recommendations, but these are context-specific to chronic bronchitis. For refractory chronic cough, the 2007 morphine study 2 represents the highest-quality evidence for a specific medication with objective outcomes.
Meta-analysis data 6 confirms opioids have the strongest effect size (0.55 for severity, 0.57 for frequency) compared to dextromethorphan (0.37 and 0.40 respectively), supporting morphine as the most effective single agent for refractory cases.
Important Caveats
- Do NOT use codeine or dextromethorphan for URI-related cough - Grade D recommendation with no benefit 1
- Do NOT use albuterol for chronic cough not due to asthma - Grade D recommendation 1
- Ipratropium bromide has Grade A recommendation for cough suppression 1 but is less commonly used as monotherapy
- Gefapixant (P2X3 antagonist) is newly approved in EU/UK/Japan 5, 7 but availability varies by region
Practical Pitfall to Avoid
The most common error is using over-the-counter combination products or central suppressants (codeine/dextromethorphan) for acute viral URI cough - these have no proven benefit and Grade D recommendations 1, 8. Reserve morphine and neuromodulators specifically for refractory chronic cough after addressing treatable underlying causes.